Sellas Life Sciences Group, Inc. · NASDAQ:SLS
Anson Funds Management LP reported a 5.70% stake in Sellas Life Sciences Group, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
Anson Funds Management LP reported a 5.70% stake in Sellas Life Sciences Group, Inc., 6,032,938 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 5.70%
- Shares
- 6,032,938
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Anson Funds Management LP | 5.70% | 6,032,938 |
| Anson Management GP LLC | 5.70% | 6,032,938 |
| Tony Moore | 5.70% | 6,032,938 |
| Anson Advisors Inc. | 5.70% | 6,032,938 |
| Amin Nathoo | 5.70% | 6,032,938 |
| Moez Kassam | 5.70% | 6,032,938 |
Source
Related
- Sellas Life Sciences Group, Inc.
- Anson Funds Management LP
- Sellas Life Sciences Group, Inc. shareholders
- Schedule 13G/A · Anson Funds Management LP · Feb 17, 2026
- Schedule 13G/A · Anson Funds Management LP · Aug 14, 2025
- Schedule 13G · Anson Funds Management LP · May 15, 2025
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Stergiou Angelos M. · Jun 18, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 24, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026